| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human TRANCE/RANK L/TNFSF11 (E. coli), CF |
|---|
| Description | Purity >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 19 kDa, reducing conditions. MW (theoretical): 18.3 kDa. The Recombinant Human TRANCE/RANK L/TNFSF11 (E. coli) from R&D Systems is derived from E. coli. The Recombinant Human TRANCE/RANK L/TNFSF11 (E. coli) has been validated for the following applications: Bioactivity. |
|---|
| Size | 10 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | CD254, CD254 antigen, ODF, OPGL, OPGLOPTB2, Osteoclast differentiation factor, Osteoprotegerin ligand, RANK L, RANKL, RANKLreceptor activator of nuclear factor kappa B ligand, Receptor activator of nuclear factor kappa-B ligand, sOdf, TNF-related activation-induced cytokine, TNFSF11, TRANCEODFhRANKL2, tumor necrosis factor (ligand) superfamily, member 11, tumor necrosis factor ligand superfamily member 11 |
|---|
| Gene, Accession, CAS # | TNFSF11, Gene ID: 8600, Accession: AAC51762 |
|---|
| Catalog # | 6449-TEC-010/CF |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human TRANCE/RANK L/TNFSF11 (E. coli), CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 27572279 |
|---|
| 产品资料 |
|
|